Trials / Completed
CompletedNCT04097704
Pharmacogenetics Sampling of the CC-90007-CP-003 Study Cohort
An Observational Follow-on Study to Describe the Pharmacogenetics of the CC-90007-CP-003 Study Cohort
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 28 (actual)
- Sponsor
- Celgene · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a multi-center observational follow-up study to collect saliva samples that allow pharmacogenetic analysis of the subjects that participated in the CC-90007-CP-003 study. Approximately 28 subjects with moderate and severe hepatic impairment and healthy control subjects with normal hepatic function will be enrolled.
Conditions
Timeline
- Start date
- 2019-09-04
- Primary completion
- 2019-11-01
- Completion
- 2019-11-01
- First posted
- 2019-09-20
- Last updated
- 2020-05-21
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04097704. Inclusion in this directory is not an endorsement.